Evidence map›Paper›PMID 41499589›Full record

ArticlePloS one2026

Investigation mechanisms of action and resistance of Edwardsiella ictaluri to trans-cinnamaldehyde.

Hossam Abdelhamed, Munshi Mustafiz Riman, Mark A Arick, Ali Sobhy Dawood, Basant Gomaa, Monzur Chowdhury, Larry A Hanson, Attila Karsi

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hossam AbdelhamedDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.ORCID https://orcid.org/0000-0003-2439-0659
Munshi Mustafiz RimanDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.
Mark A ArickInstitute for Genomics, Biocomputing and Biotechnology, Mississippi State University, Mississippi State, Mississippi, United States of America.ORCID https://orcid.org/0000-0002-7207-3052
Ali Sobhy DawoodDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.
Basant GomaaDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.
Monzur ChowdhuryDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.ORCID https://orcid.org/0000-0003-2102-7176
Larry A HansonDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.
Attila KarsiDepartment of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of multidrug-resistant (MDR) pathogens in aquaculture poses a significant threat to food safety and public health by facilitating the transfer of resistance across the food chain, underscoring the need for sustainable, non-antibiotic control measures. Trans-cinnamaldehyde (TC), a phytochemical with antimicrobial activity, is a promising alternative. While previous publications have established the antibacterial efficacy of TC against Edwardsiella ictaluri, the agent of enteric septicemia of catfish, its mechanism of action and the potential for bacterial adaptation after prolonged exposure remain undefined. Here, we addressed these gaps by investigating the antibacterial mechanism, the adaptive response of E. ictaluri to TC, and the vaccine potential of TC-adapted strains, with relevance to One-Health. The minimum inhibitory concentration (MIC) of TC against E. ictaluri was 120 µg/mL, whereas 16 µg/mL was not inhibitory and was used for long-term adaptation. Serial passages for 30 and 60 days generated D30- and D60-adapted strains. Disk diffusion assays indicated reduced susceptibility to TC and florfenicol but increased susceptibility to sulfamethoxazole/trimethoprim (SXT) in adapted strains. Virulence assays in catfish fingerlings (three tanks containing 10 fish per tank) demonstrated that D30-TC and D60-TC strains were highly attenuated. Moreover, vaccination with these strains conferred significant protection against wild-type challenge (63.64% and 73.64% survival compared to 20% in controls). Quantitative proteomics revealed the upregulation of multidrug efflux pumps and stress adaptation proteins and the downregulation of central metabolic pathways during TC exposure. Long-term adaptation was characterized by metabolic reprogramming, including enhanced energy and carbohydrate metabolism and suppression of virulence-associated secretion systems. Comparative genomics of D30-TC and D60-TC strains revealed shared mutations in genes related to membrane biosynthesis, energy metabolism, stress response, and regulatory pathways. Together, these findings highlight the potential of TC as an antimicrobial and a potential source of live-attenuated vaccine, while revealing adaptive mechanisms that may inform future strategies for controlling E. ictaluri infections.

Indexed as

AcroleinAnti-Bacterial AgentsDrug Resistance, BacterialEdwardsiella ictaluriEnterobacteriaceae InfectionsAnimalsFish DiseasesMicrobial Sensitivity TestsAcroleinAnti-Bacterial Agentscinnamaldehyde

Identifiers

PMID41499589
PMCPMC12779148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.